Skip to content
LexBuild

Animal Drugs, Feeds, and Related Products; Withdrawal of Approval of New Animal Drug Applications

---
identifier: "/us/fr/05-24103"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Animal Drugs, Feeds, and Related Products; Withdrawal of Approval of New Animal Drug Applications"
title_number: 0
title_name: "Federal Register"
section_number: "05-24103"
section_name: "Animal Drugs, Feeds, and Related Products; Withdrawal of Approval of New Animal Drug Applications"
positive_law: false
currency: "2005-12-16"
last_updated: "2005-12-16"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "05-24103"
document_type: "notice"
publication_date: "2005-12-16"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "70 FR 74822"
fr_volume: 70
docket_ids:
  - "Docket No. 2005N-0150"
effective_date: "2005-12-27"
fr_action: "Notice."
---

#  Animal Drugs, Feeds, and Related Products; Withdrawal of Approval of New Animal Drug Applications

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice.

**SUMMARY:**

The Food and Drug Administration (FDA) is withdrawing approval of 15 new animal drug applications (NADAs) because the products are no longer manufactured or marketed. In a final rule published elsewhere in this issue of the *Federal Register* , FDA is amending the animal drug regulations to remove portions reflecting approval of the NADAs.

**DATES:**

Withdrawal of approval is effective December 27, 2005.

**FOR FURTHER INFORMATION CONTACT:**

Pamela K. Esposito, Center for Veterinary Medicine (HFV-210), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-276-9067, e-mail: *[email protected]* .

**SUPPLEMENTARY INFORMATION:**

The following sponsors have requested that FDA withdraw approval of the 15 NADAs listed in table 1 of this document because the products are no longer manufactured or marketed:

| Sponsor | NADA Number, Product (Drug) | 21 CFR Section Affected (Sponsor Drug Labeler Code) |
| --- | --- | --- |
| Bioproducts, Inc., 320 Springside Dr., Suite 300, Fairlawn, OH 44333-2435 | NADA 119-063, Pyrantel Tartrate Ton Pack (pyrantel tartrate) | 558.485 (051359) |
| Farmland Industries, Inc., Kansas City, MO 64116 | NADA 138-656, BN Wormer—19.2 BANMINTH Premix (pyrantel tartrate) | 558.485 (021676) |
| I.M.S. Inc., 13619 Industrial Rd., Omaha, NE 68137 | NADA 129-395, HYGROMIX 0.6 Premix (hygromycin B) | 558.274 (050639) |
|  | NADA 129-646, TYLAN 10 Sulfa-G (tylosin, sulfamethazine) | 558.630 (050639) |
|  | NADA 136-601, Swine Guard-BN (pyrantel tartrate) | 558.485 (050639) |
| J. & R. Specialty Supply Co., 310 Second Ave., SW,, P.O. Box 506, Waseca, MN 56093 | NADA 96-780, TYLAN 10; TYLAN 40 (tylosin) | n/a (049768) |
| Kerber Milling Co., Box 152, 1817 E. Main St., Emmetsburg, IA 50536 | NADA 98-687, Hy-Test Hy-Boost TY 5 Medicated (tylosin) | 558.625 (029341) |
| M & M Livestock Products Co., Eagle Grove, IA 50533 | NADA 96-837, M & M Tylosin Premix (tylosin) | 558.625 (026282) |
| Nutra-Blend Corp., P.O. Box 485, Neosho, MO 64850 | NADA 129-161, Nutra-Blend TYLAN 10 Sulfa Premix (tylosin, sulfamethazine) | 558.630 (050568) |
|  | NADA 136-384, Swine Wormer-BN BANMINTH (pyrantel tartrate) | 558.485 (050568) |
| South St. Paul Feeds, Inc., 500 Farwell Ave., South St. Paul, MN 55075 | NADA 136-369, Custom Ban Wormer 9.6 (pyrantel tartrate) | 558.485 (001800) |
| Stockton Hay & Grain Co. | NADA 49-462, Rainbrook Broiler Premix No. 1 (ampolium, arsanilic acid, ethopabate, penicillin G procaine, streptomycin) | n/a (036541) |
|  | NADA 91-646, Rainbow Broiler Base Concentrate (ampolium, bacitracin zinc, ethopabate) | n/a (036541) |
|  | NADA 91-647, Broiler Base Concentrate (ampolium, chlortetracyline, ethopabate) | n/a (036541) |
| Triple “F”, Inc., 10104 Douglas Ave., Des Moines, IA 50322 | NADA 131-146, FLAVOMYCIN 0.4 (bambermycins) | 558.95 (011490) |

Therefore, under authority delegated to the Commissioner of Food and Drugs (21 CFR 5.10), redelegated to the Center for Veterinary Medicine (21 CFR 5.84), and in accordance with § 514.115 *Withdrawal of approval of applications* (21 CFR 514.115), notice is given that approval of NADAs 49-462, 91-646, 91-647, 96-780, 96-837, 98-687, 119-063, 129-161, 129-395, 129-646, 131-146, 136-369, 136-384, 136-601, 138-656, and all supplements and  amendments thereto, is hereby withdrawn, effective December 27, 2005.

In a final rule published elsewhere in this issue of the *Federal Register* , FDA is amending the animal drug regulations to reflect the withdrawal of approval of these NADAs.

Dated: December 7, 2005.

Stephen F. Sundlof,

Director, Center for Veterinary Medicine.